Global Sulfanilamide (CAS 63-74-1) Market Outlook 2019-2024

March 2019 | 117 pages | ID: G35620A5A48EN
Gen Consulting Company

Abstracts

The 'Global Sulfanilamide (CAS 63-74-1) Market Outlook 2019-2024' offers detailed coverage of sulfanilamide industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading sulfanilamide producers to provide exhaustive coverage of the market for sulfanilamide. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.

The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global sulfanilamide market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Key Regions

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Key Vendors

• Suzhou Wugan Pharmaceutical Co., Ltd.
• Zhejiang Chemsyn Pharm Co., Ltd.
• Chongqing Changshou Chemical Co., Ltd.
• request free sample to get a complete list of companies

Key Questions Answered in This Report

• Analysis of the sulfanilamide market including revenues, future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Profiles on sulfanilamide vendors including products, sales/revenues, SWOT, and market position, recent developments.
• Market structure, market drivers and restraints.

Contents

PART 1. SUMMARY

PART 2. REPORT METHODOLOGY

2.1 Methodology
2.2 Data Source

PART 3. INTRODUCTION

PART 4. INDUSTRY VALUE CHAIN

4.1 Sulfanilamide Industry Value Chain Analysis
4.2 Upstream
4.3 End-uses
4.4 Distributors

PART 5. COMPETITIVE LANDSCAPE

5.1 Global Sulfanilamide Sales & Share by Company (2014-2019)
5.2 Global Sulfanilamide Revenue & Share by Company (2014-2019)
5.3 Pricing Trends
5.4 Competitive Trends

PART 6. SEGMENTATION BY TYPE

6.1 Global Sulfanilamide Sales Volume by Type (2014-2019)
6.2 Global Sulfanilamide Revenue by Type (2014-2019)
6.3 Global Sulfanilamide Price by Type (2014-2019)

PART 7. SEGMENTATION BY APPLICATION

7.1 Global Sulfanilamide Sales Volume by Application (2014-2019)
7.2 Global Sulfanilamide Revenue by Application (2014-2019)
7.3 Global Sulfanilamide Price by Application (2014-2019)

PART 8. REGIONAL PERSPECTIVES

8.1 Overview
8.2 North America
  8.2.1 Market Size (Volume & Value)
  8.2.2 by Application
  8.2.3 by Country (U.S., Canada, Mexico, etc.)
8.3 Europe
  8.3.1 Market Size (Volume & Value)
  8.3.2 by Application
  8.3.3 by Country (Germany, UK, France, Spain, Italy, etc.)
8.4 Asia-Pacific
  8.4.1 Market Size (Volume & Value)
  8.4.2 by Application
  8.4.3 by Country (China, Japan, Korea, India, etc.)
8.5 Middle East & Africa
  8.5.1 Market Size (Volume & Value)
  8.5.2 by Application
  8.5.3 by Country (Saudi Arabia, Turkey, Nigeria, Iran, South Africa, etc.)
8.6 South America
  8.6.1 Market Size (Volume & Value)
  8.6.2 by Application
  8.6.3 by Country (Brazil, Argentina, Colombia, etc.)

PART 9. COMPANY PROFILES

9.1 Company Profile
9.2 Product Offered
9.3 Business Performance
9.4 Recent Developments

PART 10. MARKET FORECAST

10.1 Global Sulfanilamide Market Size Forecast (2019-2024)
  10.1.1 Global Sulfanilamide Sales Forecast (2019-2024)
  10.1.2 Global Sulfanilamide Revenue Forecast (2019-2024)
10.2 Forecast by Region
  10.2.1 North America
  10.2.2 Europe
  10.2.3 Asia-Pacific
  10.2.4 Middle East & Africa
  10.2.5 South America
10.3 Forecast by Type
10.4 Forecast by Application

PART 11. MARKET DRIVERS

11.1 Opportunities
11.2 Challenges
11.3 Economic/Political Environmental

PART 12. INDUSTRY ACTIVITY

12.1 M&As, JVs and Partnership
12.2 Other Developments

PART 13. APPENDIX

DISCLAIMER
ABOUT GEN CONSULTING COMPANY